Potential therapeutic applications of circular RNA in acute kidney injury

Zheng Li1, Jihong Xing1

  • 1Department of Emergency Medicine, The First Hospital of Jilin University, Changchun, Jilin 130021, China.

Insights

Circular RNAs (circRNAs) are key regulators in gene expression and are implicated in acute kidney injury (AKI) development. This review explores circRNA

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Nephrology

Background:

  • Acute kidney injury (AKI) is a prevalent clinical syndrome with increasing morbidity and mortality.
  • Current treatment options for AKI are limited, and many patients progress to chronic kidney disease.
  • Circular RNAs (circRNAs) are non-coding RNAs involved in gene regulation and disease development.

Purpose of the Study:

  • To review the current research status and progress of circRNAs in the context of AKI.
  • To highlight the role of circRNAs in biological processes relevant to AKI, such as apoptosis, oxidative stress, and inflammation.
  • To discuss the potential of circRNAs as diagnostic and prognostic markers for AKI.

Main Methods:

  • Literature review of studies on circRNAs and AKI.
  • Analysis of circRNA involvement in gene expression regulation.
  • Examination of circRNA's role in apoptosis, oxidative stress, and inflammation in AKI models.

Main Results:

  • CircRNAs play a significant role in the occurrence and development of AKI.
  • CircRNAs act as competing RNAs, influencing gene expression.
  • CircRNAs are implicated in regulating key biological processes like apoptosis, oxidative stress, and inflammation in AKI.

Conclusions:

  • CircRNAs are critically involved in the pathogenesis of AKI.
  • CircRNAs hold promise as potential diagnostic and prognostic biomarkers for AKI.
  • Further research into circRNAs could lead to novel therapeutic strategies for AKI.

Related Concept Videos

Antihypertensive Drugs: Direct Renin Inhibitors01:25

Antihypertensive Drugs: Direct Renin Inhibitors

The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
616
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
424
Dialysis01:27

Dialysis

Renal failure occurs when the kidneys lose their ability to filter waste products from the blood effectively. It can be classified into two types: acute renal failure (ARF) and chronic renal failure (CRF).
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
307